Literature DB >> 20033667

Enhanced trafficking to the pancreatic lymph nodes and auto-antigen presentation capacity distinguishes peritoneal B lymphocytes in non-obese diabetic mice.

C Alam1, S Valkonen, S Ohls, K Törnqvist, A Hänninen.   

Abstract

AIMS/HYPOTHESIS: NOD.Igmicro ( null ) mice lacking mature B cells are highly resistant to diabetes and display poor CD4 T cell responses to autoantigens. Nevertheless, the degree to which different B cell subsets contribute to diabetes in NOD mice remains unresolved. Due to their role in the recognition of microbial and autoantigens, peritoneal B cell characteristics were examined in NOD mice to see if they differ developmentally, phenotypically or functionally in aspects relevant to diabetogenesis.
METHODS: The population dynamics, activation state, migratory behaviour and antigen presentation function were investigated in NOD peritoneal B cells.
RESULTS: NOD peritoneal B cells were found to express abnormally high levels of co-stimulatory molecules (CD40, CD86 and CD69). In contrast, the expression of L-selectin and integrin alpha4beta1 was markedly reduced in NOD mice compared with BALB/c and C57BL/6 mice. The number of B cells in the peritoneum was lower in NOD than in control mice throughout development; migration of B cells from the peritoneum to the pancreatic lymph nodes in NOD mice was enhanced tenfold. NOD B cells showed no chemotactic response to sphingosine-1-phosphate, which normally acts to retain B cells in the peritoneum. Peritoneal B cells of NOD mice also presented insulin autoantigen to CD4 T cells, inducing T cell proliferation. CONCLUSIONS/
INTERPRETATION: NOD peritoneal B cells are hyperactivated, migrate to the pancreatic lymph nodes and are capable of driving insulin-specific CD4 T cell activation. These characteristics could make them important for inducing or amplifying T cell responses against islet-antigens.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20033667     DOI: 10.1007/s00125-009-1599-x

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  29 in total

1.  Sphingosine 1-phosphate receptor expression profile and regulation of migration in human thyroid cancer cells.

Authors:  Sonja Balthasar; Johanna Samulin; Hanna Ahlgren; Nina Bergelin; Mathias Lundqvist; Emil C Toescu; Margaret C Eggo; Kid Törnquist
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

2.  Endocrine self and gut non-self intersect in the pancreatic lymph nodes.

Authors:  Shannon J Turley; Je-Wook Lee; Nick Dutton-Swain; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-29       Impact factor: 11.205

3.  Peritoneal B-2 cells comprise a distinct B-2 cell population with B-1b-like characteristics.

Authors:  William D Hastings; Joseph R Tumang; Timothy W Behrens; Thomas L Rothstein
Journal:  Eur J Immunol       Date:  2006-05       Impact factor: 5.532

Review 4.  Origin of murine B cell lineages.

Authors:  A B Kantor; L A Herzenberg
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

Review 5.  CD69 and regulation of the immune function.

Authors:  R Marzio; J Mauël; S Betz-Corradin
Journal:  Immunopharmacol Immunotoxicol       Date:  1999-08       Impact factor: 2.730

6.  Finding a way out: lymphocyte egress from lymphoid organs.

Authors:  Susan R Schwab; Jason G Cyster
Journal:  Nat Immunol       Date:  2007-12       Impact factor: 25.606

7.  Phenotype and functional characteristics of islet-infiltrating B-cells suggest the existence of immune regulatory mechanisms in islet milieu.

Authors:  Maria Carmen Puertas; Jorge Carrillo; Xavier Pastor; Rosa Maria Ampudia; Aurora Alba; Raquel Planas; Ricardo Pujol-Borrell; Marta Vives-Pi; Joan Verdaguer
Journal:  Diabetes       Date:  2007-04       Impact factor: 9.461

8.  CD11b expression distinguishes sequential stages of peritoneal B-1 development.

Authors:  Eliver Eid Bou Ghosn; Yang Yang; James Tung; Leonard A Herzenberg; Leonore A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-28       Impact factor: 11.205

9.  Peritoneal B cells govern the outcome of diabetes in non-obese diabetic mice.

Authors:  Peggy L Kendall; Emily J Woodward; Chrys Hulbert; James W Thomas
Journal:  Eur J Immunol       Date:  2004-09       Impact factor: 5.532

10.  Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse.

Authors:  D J Lenschow; S C Ho; H Sattar; L Rhee; G Gray; N Nabavi; K C Herold; J A Bluestone
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

View more
  12 in total

Review 1.  The double life of a B-1 cell: self-reactivity selects for protective effector functions.

Authors:  Nicole Baumgarth
Journal:  Nat Rev Immunol       Date:  2010-12-10       Impact factor: 53.106

2.  Innate stimulation of B1a cells enhances the autoreactive IgM repertoire in the NOD mouse: implications for type 1 diabetes.

Authors:  J Côrte-Real; N Duarte; L Tavares; C Penha-Gonçalves
Journal:  Diabetologia       Date:  2012-03-01       Impact factor: 10.122

3.  Visualization of mouse pancreas architecture using MR microscopy.

Authors:  Paul J Grippo; Palamadai N Venkatasubramanian; Richard H Knop; Daniel M Heiferman; Gheorghe Iordanescu; Laleh G Melstrom; Kevin Adrian; Morgan R Barron; David J Bentrem; Alice M Wyrwicz
Journal:  Am J Pathol       Date:  2011-05-31       Impact factor: 4.307

4.  Casein hydrolysate diet controls intestinal T cell activation, free radical production and microbial colonisation in NOD mice.

Authors:  R Emani; M N Asghar; R Toivonen; L Lauren; M Söderström; D M Toivola; E A F van Tol; A Hänninen
Journal:  Diabetologia       Date:  2013-06-08       Impact factor: 10.122

Review 5.  Functional alterations of proinflammatory monocytes by T regulatory cells: implications for the prevention and reversal of type 1 diabetes.

Authors:  Charles Sia; Arno Hänninen
Journal:  Rev Diabet Stud       Date:  2010-05-10

6.  Effects of a germ-free environment on gut immune regulation and diabetes progression in non-obese diabetic (NOD) mice.

Authors:  C Alam; E Bittoun; D Bhagwat; S Valkonen; A Saari; U Jaakkola; E Eerola; P Huovinen; A Hänninen
Journal:  Diabetologia       Date:  2011-03-05       Impact factor: 10.122

Review 7.  Effects of Moringa oleifera aqueous leaf extract in alloxan induced diabetic mice.

Authors:  Muobarak J Tuorkey
Journal:  Interv Med Appl Sci       Date:  2016-09

8.  Human-derived natural antibodies: biomarkers and potential therapeutics.

Authors:  Xiaohua Xu; Sher May Ng; Eamonn Hassouna; Arthur Warrington; Sang-Hyun Oh; Moses Rodriguez
Journal:  Future Neurol       Date:  2015

Review 9.  B cell depletion in autoimmune diabetes: insights from murine models.

Authors:  Jayne L Chamberlain; Kesley Attridge; Chun Jing Wang; Gemma A Ryan; Lucy Sk Walker
Journal:  Expert Opin Ther Targets       Date:  2011-03-03       Impact factor: 6.902

10.  Inflammatory tendencies and overproduction of IL-17 in the colon of young NOD mice are counteracted with diet change.

Authors:  Catharina Alam; Suvi Valkonen; Vindhya Palagani; Jari Jalava; Erkki Eerola; Arno Hänninen
Journal:  Diabetes       Date:  2010-06-14       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.